Dashboard
Fundings
Executives
Acquisitions
Agreements
Products
Crowdfundings
Family Offices
NEW
FundzWatch™
Trends
Favorites
Exports
Dashboard
Fundings
Executives
Acquisitions
Agreements
Products
Crowdfundings
Family Offices
NEW
FundzWatch™
Trends
Favorites
Exports
Ashvattha Therapeutics Rallies $69M Series B
Ashvattha Therapeutics Rallies $69M Series B
04/27/22, 2:47 PM
Money raised
$69 million
Round Type
series b
Ashvattha Therapeutics, a developer of novel hydroxyl dendrimer therapeutics, has secured $69 million in Series B financing.
Company Info
Company
Ashvattha Therapeutics
